The Michael J. Fox Foundation has awarded grants to support research on Parkinson's disease, including the development of new therapies and tools to track the disease. The grants are part of a larger funding effort, with reported totals ranging from $62.4 million to $67 million, to advance various projects and studies. Specific recipients of the grants include companies such as X-tosis and Neuron23, as well as institutions like Boston University, which will study treatments and devices for Parkinson's disease.